MarketStar Founder Alan Hall Joins MediConnect Board of Directors
* Reuters is not responsible for the content in this press release.
SALT LAKE CITY--(Business Wire)-- MediConnect Global, Inc. is pleased to announce Alan E. Hall as the newest member of its Board of Directors. "We are honored to have Alan Hall join our Board of Directors," said CEO Amy Rees Anderson. "Alan`s entrepreneurial experience and exceptional leadership capabilities will be a tremendous asset to the company as we continue to lead the charge of digitizing medical records across the globe." Hall is the founder and chairman of MarketStar Corporation, a global outsourced marketing and sales company focused on assisting high-technology companies increase sales in small to medium business sectors. MarketStar, owned by Omnicom Group (OMC), generates billions of dollars in sales for its clientele. Hall is also the founder and chairman of Grow Utah Ventures, a not-for-profit entity with a mission of stimulating economic development through entrepreneurship. Recently, Hall established Mercato Partners, a growth equity venture capital firm which invests in high-growth technology companies. Hall is the chairman of the Utah Technology Council, a trustee of Weber State University, a member of the Advisory Board of Wells Fargo Bank, and a trustee of the Intermountain Healthcare Foundation. He has been the recipient of the Ernst & Young and Mountain West Capital Network Entrepreneur of the Year awards. About MediConnect Global MediConnect Global, Inc. is the leading medical records retrieval, scanning, and storage services provider. MediConnect`s online RapidRetrieve system and patented processes provide medical records over the internet in a secure and efficient manner. It also provides global healthcare services. For more information, please visit (http://www.mediconnect.net) or call (801) 545-3700. MediConnect Global Inc. Elyse Peterson, 801-545-3717 epeterson@mediconnect.net Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters